The technology is genuinely useful for scientific discovery, but its applications are less dramatic than you might think.

Champions Oncology, Inc.’s CSBR share price has surged by 7.56%, which has investors questioning if this is right time to ...

Survey results revealed a widespread - and often misguided - belief that subcutaneous delivery volumes must be limited to 3 ...

Eight healthcare AI startups made CB Insights’ ninth annual AI 100 list of the top emerging AI companies. The market researcher picked the winners based on factors including deal activity, industry ...

Precision oncology company Guardant Health has announced a strategic collaboration with Pfizer to support the development and ...

The collaboration reflects Ebn Sina Medical’s commitment to delivering high-quality medicinal products to the local market, ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Our global Injectables business is delivering a solid revenue performance, driven by each of our three geographies ...

AstraZeneca has started work with tech companies Tempus and Pathos AI on a project that aims to generate a wide-ranging and ...

As a stock-picking sector, investors can benefit from deep fundamental research on individual biotech companies ...

Tempus stands to earn $200 million in data licensing and model development fees from the collaborations, the release said.